Page last updated: 2024-11-11

5-hydroxydantrolene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-hydroxydantrolene: dantrolene metabolte [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9577331
CHEMBL ID3276937
CHEBI ID174443
SCHEMBL ID12417198
MeSH IDM0105727

Synonyms (17)

Synonym
52130-25-3
CHEBI:174443
5-hydroxy-1-[(e)-[5-(4-nitrophenyl)uran-2-yl]methylideneamino]imidazolidine-2,4-dione
brn 0899668
2,4-imidazolidinedione, 5-hydroxy-1-(((5-(4-nitrophenyl)-2-furanyl)methylene)amino)-
5-hydroxydantrolene
5-hydroxy-1-(((5-(4-nitrophenyl)-2-furanyl)methylene)amino)-2,4-imidazolidinedione
y9s8199rfw ,
unii-y9s8199rfw
5-hydroxy dantrolene
CHEMBL3276937
5-hydroxy-dantrolene
SCHEMBL12417198
5-hydroxy-1-[(e)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]imidazolidine-2,4-dione
5-hydroxy-1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidinedione;
2,4-imidazolidinedione,5-hydroxy-1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-
5-hydroxy-1-(((5-(4-nitrophenyl)furan-2-yl)methylene)amino)imidazolidine-2,4-dione

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The half-life of 5-hydroxydantrolene was shorter than that of the parent drug as demonstrated by administration of the metabolite."( Pharmacokinetics of intravenously administered dantrolene and its 5-hydroxy metabolite in dogs.
Van Der Kleijn, E; Vree, TB; Wuis, EW, 1990
)
0.61
" Thereafter, the concentration of dantrolene decreased slowly with an elimination half-life (mean +/- SD) of 10."( Pharmacokinetics of intravenous dantrolene in children.
Lerman, J; McLeod, ME; Strong, HA, 1989
)
0.28
" For the pharmacokinetic portion of the study, a randomized, balanced 2-way crossover design was employed wherein eight healthy horses received a single oral dose of either capsules or paste followed by a 4 week washout period prior to administration of the second formulation to the same horse."( Pharmacokinetics and metabolism of dantrolene in horses.
Arthur, RM; DiMaio Knych, HK; Moeller, BC; Stanley, SD; Taylor, A, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
imidazolidine-2,4-dioneAn imidazolidinone with oxo groups at position 2 and 4.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID1148308Inhibition of twitch in Charles River rat diaphragm at 60 mg/L after 5 mins1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Synthesis and comparative skeletal muscle relaxant activity of some 2,4-imidazolidinediones and their corresponding 5-hydroxy-2,4-imidazolidinediones.
AID1148300Induction of skeletal muscle relaxation in ip dosed albino mouse after 60 mins1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Synthesis and comparative skeletal muscle relaxant activity of some 2,4-imidazolidinediones and their corresponding 5-hydroxy-2,4-imidazolidinediones.
AID1148301Inhibition of gastrocnemius twitch in Sprague-Dawley rat at cumulative dose of 36.6 mg/kg, iv relative to control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Synthesis and comparative skeletal muscle relaxant activity of some 2,4-imidazolidinediones and their corresponding 5-hydroxy-2,4-imidazolidinediones.
AID1148302Inhibition of gastrocnemius twitch in iv dosed Sprague-Dawley rat1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Synthesis and comparative skeletal muscle relaxant activity of some 2,4-imidazolidinediones and their corresponding 5-hydroxy-2,4-imidazolidinediones.
AID1148299Induction of skeletal muscle relaxation in po dosed albino mouse after 60 mins1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Synthesis and comparative skeletal muscle relaxant activity of some 2,4-imidazolidinediones and their corresponding 5-hydroxy-2,4-imidazolidinediones.
AID1148303Induction of straub tail relaxation in albino mouse assessed as gain of righting reflex in 1 min1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Synthesis and comparative skeletal muscle relaxant activity of some 2,4-imidazolidinediones and their corresponding 5-hydroxy-2,4-imidazolidinediones.
AID1148305Muscle relaxant efficacy index, ratio of ED50 for muscle incoordination in mouse to ED50 for induction of straub tail relaxation in albino mouse1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Synthesis and comparative skeletal muscle relaxant activity of some 2,4-imidazolidinediones and their corresponding 5-hydroxy-2,4-imidazolidinediones.
AID1148304Induction of muscle incoordination in mouse after 30 mins by rotarod test1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Synthesis and comparative skeletal muscle relaxant activity of some 2,4-imidazolidinediones and their corresponding 5-hydroxy-2,4-imidazolidinediones.
AID1148306Toxicity in albino mouse after 72 hrs1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Synthesis and comparative skeletal muscle relaxant activity of some 2,4-imidazolidinediones and their corresponding 5-hydroxy-2,4-imidazolidinediones.
AID1918192Inhibition of human OAT2 tv.1 variant expressed in HEK293 cells assessed as inhibition of [3H]cGMP uptake by scintillation analysis2022Journal of medicinal chemistry, 11-10, Volume: 65, Issue:21
Identification of Organic Anion Transporter 2 Inhibitors: Screening, Structure-Based Analysis, and Clinical Drug Interaction Risk Assessment.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (66.67)18.7374
1990's1 (11.11)18.2507
2000's0 (0.00)29.6817
2010's1 (11.11)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.23 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]